The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

Second biggest killer after lung cancer. WHO ... HOW MANY? 21,000. Second most common male cancer. SURVIVAL RATE: 50%. WHO? Men aged over 60. Half of sufferers are over 75. Risk factors: family ...

A new NIH-led study finds rising rates of 14 cancer types in Americans under 50, especially breast, colorectal, kidney, ...

Eighty-five percent of diagnosed cases of lung cancer are non-small ... this oncogene — one of the most effective strategies against this type of cancer — has benefited many patients.

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Cindy was a healthy, 35-year-old woman with no symptoms of cancer when she joined the American Lung Association’s Lung Health ...

Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park Comprehensive Cancer Center.

Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an oncologist recommends.

Opdivo (nivolumab) is a brand-name IV infusion prescribed for non-small cell lung cancer (NSCLC) in some situations. This article covers topics such as side effects, dosage, and how Opdivo works.

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL ...

Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of origin’ of the second most common lung cancer ...